These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36244328)

  • 21. Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.
    Derks S; de Klerk LK; Xu X; Fleitas T; Liu KX; Liu Y; Dietlein F; Margolis C; Chiaravalli AM; Da Silva AC; Ogino S; Akarca FG; Freeman GJ; Rodig SJ; Hornick JL; van Allen E; Li B; Liu SX; Thorsson V; Bass AJ
    Ann Oncol; 2020 Aug; 31(8):1011-1020. PubMed ID: 32387455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTNNBIP1 downregulation is associated with tumor grade and viral infections in gastric adenocarcinoma.
    Kosari-Monfared M; Nikbakhsh N; Fattahi S; Ghadami E; Ranaei M; Taheri H; Amjadi-Moheb F; Godazandeh GA; Shafaei S; Pilehchian-Langroudi M; Samadani AA; Akhavan-Niaki H
    J Cell Physiol; 2019 Mar; 234(3):2895-2904. PubMed ID: 30076728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
    Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
    Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan.
    Yoshida T; Ogura G; Tanabe M; Hayashi T; Ohbayashi C; Azuma M; Kunisaki C; Akazawa Y; Ozawa S; Matsumoto S; Suzuki T; Mitoro A; Fukunaga T; Shimizu A; Fujimoto G; Yao T
    Cancer Biol Ther; 2022 Dec; 23(1):191-200. PubMed ID: 35220884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
    Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
    World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
    Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
    Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of microsatellite status and EBV infection with clinical characteristics of patients with gastric cancer.
    Lu P; Yushan K; Yusufu G; Wang H; Mao R
    Gen Physiol Biophys; 2023 Sep; 42(5):403-415. PubMed ID: 37702446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
    Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W
    Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
    Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
    Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular subtype switching in early-stage gastric cancers with multiple occurrences.
    Takaoka S; Hirotsu Y; Ohyama H; Mochizuki H; Amemiya K; Oyama T; Ashizawa H; Yoshimura D; Nakagomi K; Hosoda K; Suzuki Y; Kojima Y; Omata M
    J Gastroenterol; 2019 Aug; 54(8):674-686. PubMed ID: 30666417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration in stemness causes exclusivity between Epstein-Barr virus-positivity and microsatellite instability status in gastric cancer.
    Kim Y; Shin YJ; Wen X; Cho NY; Li M; Kim YJ; Song SH; Kang GH
    Gastric Cancer; 2021 May; 24(3):602-610. PubMed ID: 33386473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma.
    Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A
    J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular profile of gastric adenocarcinoma, relevant epidemiological factors - Systematic review and meta-analysis relating sex with Epstein-Barr virus and unstable microsatellites subtypes.
    Santos GOD; Nunes WA; Júnior WF; Botega LG; Roehe AV
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):109-118. PubMed ID: 37932908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
    Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
    Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients.
    Shen H; Zhong M; Wang W; Liao P; Yin X; Rotroff D; Knepper TC; Mcleod HL; Zhou C; Xie S; Li W; Xu B; He Y
    Clin Chim Acta; 2017 Aug; 471():216-221. PubMed ID: 28601671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct genomic profile in h. pylori-associated gastric cancer.
    Zhang X; Liu F; Bao H; Wang A; Han M; Wu X; Gu Y; Zheng L
    Cancer Med; 2021 Apr; 10(7):2461-2469. PubMed ID: 33751865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.
    Gulley ML
    Exp Mol Med; 2015 Jan; 47(1):e134. PubMed ID: 25613731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
    Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
    J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
    Derks S; Liao X; Chiaravalli AM; Xu X; Camargo MC; Solcia E; Sessa F; Fleitas T; Freeman GJ; Rodig SJ; Rabkin CS; Bass AJ
    Oncotarget; 2016 May; 7(22):32925-32. PubMed ID: 27147580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.